Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2016
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2017
Report date:
2016

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
3-amino-4-methoxy-N-methylbenzamide
EC Number:
813-034-3
Cas Number:
878160-14-6
Molecular formula:
C9H12N2O2
IUPAC Name:
3-amino-4-methoxy-N-methylbenzamide
Test material form:
solid: particulate/powder
Specific details on test material used for the study:
Purity: 99.9 % (w/w)

Method

Species / strain
Species / strain / cell type:
other: TA 1535, TA 1537, TA 98, TA 100, and WP2 uvrA
Additional strain / cell type characteristics:
not applicable
Metabolic activation:
with and without
Metabolic activation system:
Phenobarbital/Beta-naphthoflavone induced rat liver S9
Test concentrations with justification for top dose:
Pre-Experiment/Experiment I: 3; 10; 33; 100; 333; 1000; 2500; and 5000 µg/plate

Vehicle / solvent:
Solvent used: DMSO
Justification for choice of solvent: best suitable solvent, because of its solubility properties and its relative nontoxicity to the bacteria
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
sodium azide
methylmethanesulfonate
other: 4-nitro-o-phenylene-diamine, 2-aminoanthracene
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation)

exposure duration: 72 hours

Number of replications: 3 plates (each concentration including controls)

DETERMINATION OF CYTOTOXICITY: Evident as a reduction in the number of spontaneous revertants (below the induction factor of 0.5) or a clearing of the bacterial background lawn.
Evaluation criteria:
A test item is considered as a mutagen if a biologically relevant increase in the number of revertants exceeding the threshold of twice (strains TA 98, TA 100, and WP2 uvrA) or thrice (strains TA 1535 and TA 1537) the colony count of the corresponding solvent control is observed.
A dose dependent increase is considered biologically relevant if the threshold is exceeded at more than one concentration.
An increase exceeding the threshold at only one concentration is judged as biologically relevant if reproduced in an independent second experiment.
A dose dependent increase in the number of revertant colonies below the threshold is regarded as an indication of a mutagenic potential if reproduced in an independent second experiment. However, whenever the colony counts remain within the historical range of negative and solvent controls such an increase is not considered biologically relevant.
Statistics:
According to the OECD guideline 471, a statistical analysis of the data is not mandatory.

Results and discussion

Test results
Species / strain:
other: TA 1535, TA 1537, TA 98, TA 100, and WP2 uvrA
Metabolic activation:
with and without
Genotoxicity:
positive
Remarks:
in strains TA 1537 and TA 98 in the presence of metabolic activation (S9 mix)
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
TEST SPECIFIC CONFOUNDING FACTORS
Effects of pH: none
Water solubility: not soluble
Precipitation: No precipitation of the test item occurred up to the highest investigated dose.
Other confounding effects: none

COMPARISON WIT HISTORICAL CONTROL DATA: performed
ADDITIONAL INFORMATION ON CYTOTOXICITY: No toxic effects, evident as a reduction in the number of revertants (below the indication factor of 0.5), occurred in the test groups with and without metabolic activation.
Remarks on result:
other:
Remarks:
, the test item did induce gene mutations by frameshifts in the genome of strain TA 1537 and TA 98

Any other information on results incl. tables

Summary of Experiment I

Date plated: 01 November 2016

Date counted: 04 November 2016

   Test Group

 Dose Level

per Plate

TA 1535

Revertant Colony Counts

( Mean±SD)

 

TA 1537 

Revertant Colony Counts

( Mean±SD)

 

TA 98 

Revertant Colony Counts

( Mean±SD)

 

TA 100 

Revertant Colony Counts

( Mean±SD)

 

WP2 uvrA 

Revertant Colony Counts

( Mean±SD)

               
 Without  Solvent    20 ± 6  10 ± 1  22 ± 5  167 ± 3  42 ± 11
 Activation  Untreated    22 ± 4  8 ± 2  21 ± 2  153 ± 9  46 ± 4
  Test Item  3 µg 18 ± 9 ± 27 ± 9 159 ± 20 36 ± 5
     10 µg  16 ± 1  8 ± 3  25 ± 4  155 ± 4  34 ± 5
     33 µg  23 ± 7  10 ± 4  30 ± 8  159 ± 9  24 ± 8
     100 µg  22 ± 4  10 ± 3  21 ± 5  162 ± 10  40 ± 6
     333 µg  16 ± 4  10 ± 5  23 ± 3  147 ± 19  34 ± 3
     1000 µg  22 ± 1  11 ± 3  21 ± 2  152 ± 8  139 ± 8
     2500 µg  21 ± 5  8 ± 2  20 ± 7  164 ± 21  28 ± 2
     5000 µg  21 ± 5  7 ± 2  24 ± 8  166 ± 17  27 ± 4
   NaN3  10 µg  1526 ± 89      2477 ± 91  
   4 -NOPD  10 µg    554 ± 69    
   4 -NOPD  50 µg     85 ± 21      
   MMS  2.0 µL          1043 ± 25
               


With  DMSO   17 ±  10 ± 1  36 ± 5  109 ± 11  39 ± 2
 Activation  Untreated    11 ± 2  14 ± 5  36 ± 4  139 ± 13  53 ± 8
   Test Item  3µg  14 ± 3  9 ± 2  40 ± 5  95 ± 11  47 ± 6
     10µg  15 ± 1  10 ± 4  39 ± 8  96 ± 12  48 ± 6
     33µg  16 ± 6  10 ± 4  32 ± 8  106 ± 19  45 ± 4
     100µg  11 ± 4  13 ± 2  49 ± 11  91 ± 17  48 ± 8
     333µg  14 ± 3  14 ± 3  71 ± 7  118 ± 1  43 ± 11
     1000µg  10 ± 2  27 ± 0  116 ± 5  146 ± 17  44 ± 4
     2500µg  11 ± 4  30 ± 3  180 ± 25  180 ± 7  51 ± 7
     5000µg  14 ± 2  41 ± 6  255 ± 8  186 ± 19  44 ± 11
   2 -AA  2.5µg  396 ± 25  143 ± 27  3757 ± 723  3936 ± 184  
   2 -AA   10µg          328 ± 34

Key to positive controls:

NaN3: sodium azide

4 -NOPD: 4 -nitro-o-phenylene-diamine

MMS: methyl methane sulfonate

2-AA: 2 -aminoanthracene

Applicant's summary and conclusion

Conclusions:
In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, the test item did induce gene mutations by frameshifts in the genome of strains TA 1537 and TA 98 in the presence of metabolic activation (S9 mix).
Therefore, 3-Amino-4-methoxy-N-methylbenzamide is considered to be mutagenic in this Salmonella typhimurium and Escherichia coli reverse mutation assay.
Executive summary:

The test item 3-Amino-4-methoxy-N-methylbenzamide was assessed for its potential to induce gene mutations according to the plate incorporation test usingSalmonellatyphimuriumstrains TA 1535, TA 1537, TA 98, TA 100, and theEscherichia colistrain WP2 uvrA.

The assay was performed with and without rat liver microsomal activation. Each concentration and the controls were tested in triplicate. The test item was tested at the following concentrations:

3; 10; 33; 100; 333; 1000; 2500; and 5000 µg/plate

No precipitation of the test item occurred up to the highest investigated dose.

 

The plates incubated with the test item showed normal back­ground growth up to 5000 µg/plate with and without S9 mix in all strains used.

 

No toxic effects, evident as a reduction in the number of revertants (below the indication factor of 0.5), occurred in the test groups with and without metabolic activation.

Substantial increases in revertant colony numbers was observed following treatment with 3-Amino-4-methoxy-N-methylbenzamide in strains TA 1537 and TA 98 in the presence of metabolic activation (S9 mix). In strain 1537 the threshold of thrice the number of the corresponding solvent control was exceeded from 2500 to 5000 µg/plate. In strain TA 98 the threshold of twice the number of the corresponding solvent control was exceeded form 1000 to 5000 µg/plate.

A slight and dose dependent increase in the number of revertants was also detected in strain TA 100 with metabolic actvation (S9 mix) but the threshold of two was not reached.

 

Appropriate reference mutagens were used as positive controls. They showed a distinct in­crease in induced revertant colonies.